Order Entry
Denmark
ContactUsLinkComponent
Human Recombinant IP-10 (CXCL10)
Human Recombinant IP-10 (CXCL10)
Catalog # STMC78165.1
CAS Number:  
undefined
Human Recombinant IP-10 (CXCL10)
Catalog # STMC78165.1
CAS Number:  

Specifications

  • Pk:
    50 µG
  • Protein/peptide type:
    Recombinant
  • Source:
  • Species:
    Human
  • Seq:
    1202
  • Environmentally Preferable:
  • Protein synonyms:
    10 kDa interferon-gamma-induced protein|C7|crg-2|Chemokine (C-X-C motif) ligand 10|CXCL10|Gamma-IP-10|gIP-10|IFI10|INP10|mob1|SCYB10|Small inducible cytokine B10
  • Protein/peptide name:
    IP-10 (CXCL10)
  • Purity:
    ≥95%

Specifications

About this item

Interferon gamma-inducible protein (IP) 10 or CXCL10 is a member of the CXC chemokine family. It binds CXCR3 activating ERK1/2, p38/MAPK, JNK, and PI3-kinase/AKT signaling pathways, inducing intracellular calcium influx, DNA synthesis, cell proliferation, and chemotaxis. IP-10 regulates innate and adaptive immune responses by affecting the function of activated T cells, natural killer cells, inflammatory dendritic cells, macrophages, and B cells. IP-10 is produced by leukocytes, activated neutrophils, eosinophils, monocytes, epithelial cells, endothelial cells, fibroblasts, and keratinocytes in response to IFN-gamma. IP-10 has been implicated in a wide range of diseases, including infectious diseases and chronic inflammatory and autoimmune diseases, as well as in tumor formation (Liu et al.).

Caution: Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').